Antongiulio Faggiano

Pubblicazioni

Titolo Pubblicato in Anno
Immune Checkpoint Inhibitors. New Weapons Against Medullary Thyroid Cancer? FRONTIERS IN ENDOCRINOLOGY 2021
Case Report. Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers FRONTIERS IN ENDOCRINOLOGY 2021
Sunitinib treatment for advanced paraganglioma: case report of a novel SDHD gene mutation variant and systematic review of the literature FRONTIERS IN ONCOLOGY 2021
Pathology reporting in neuroendocrine neoplasms of the digestive system: everything you always wanted to know but were too afraid to ask FRONTIERS IN ENDOCRINOLOGY 2021
NETest: a systematic review focusing on the prognostic and predictive role NEUROENDOCRINOLOGY 2021
Erectile dysfunction and diabetes. A melting pot of circumstances and treatments DIABETES/METABOLISM RESEARCH AND REVIEWS 2021
Female sexual dysfunction in primary adrenal insufficiency JOURNAL OF CLINICAL MEDICINE 2021
Neuroendocrine Neoplasms with Peculiar Biology and Features. MEN1, MEN2A, MEN2B, MEN4, VHL, NF1 Neuroendocrine Neoplasia Management. New Approaches for Diagnosis and Treatment 2021
Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms? FRONTIERS IN ENDOCRINOLOGY 2021
Commentary: case report: abdominal lymph node metastases of parathyroid carcinoma: diagnostic workup, molecular diagnosis, and clinical management FRONTIERS IN ENDOCRINOLOGY 2021
Multiparametric ultrasound evaluation of a case of bilateral carotid body tumor JOURNAL OF ULTRASOUND 2021
Somatostatin analogue therapy in men1-related pancreatic neuroendocrine tumors from evidence to clinical practice: a systematic review PHARMACEUTICALS 2021
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy CANCERS 2021
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2021
Chronotype. what role in the context of gastroenteropancreatic neuroendocrine tumors? JOURNAL OF TRANSLATIONAL MEDICINE 2021
Foreword to the special issue on advances in neuroendocrine neoplasms REVIEWS IN ENDOCRINE & METABOLIC DISORDERS 2021
Neoadjuvant Therapy for Neuroendocrine Neoplasms. Recent Progresses and Future Approaches FRONTIERS IN ENDOCRINOLOGY 2021
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper ESMO OPEN 2021
Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors FRONTIERS IN ENDOCRINOLOGY 2021
Pancreatic Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1. Diagnostic Value of Different MRI Sequences NEUROENDOCRINOLOGY 2021

ERC

  • LS2_1
  • LS2_14
  • LS4_4
  • LS4_9
  • LS4_12
  • LS7_4
  • LS7_8
  • LS7_10
  • LS7_14

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

La principale area di ricerca sono è l'endocrinologia oncologica con numerose pubblicazioni e progetti clinici e traslazionali sulle neoplasie neuroendocrine, le neoplasie tiroidee, l'iperparatiroidismo, i tumori ipofisari, i feocromocitomi e paragangliomi, le sindromi neoplastiche genetiche multiendocrine. In tale ambito l'interesse di ricerca va dagli studi epidemiologici e di valutazione di fattori prognostici clinici e molecolari, studi sul ruolo della sindrome metabolica, della nutrizione e dei fatoori ambientali sulle neoplasie endocrine e neuroendocrine, studi genetici (ricerca nuove mutazioni, VUS, screening genetico, analisi NGS), studi diagnostici sulla diagnosi biochimica e ormonale e la diagnosi di imaging, studi terapeutici sull'efficacia e tossicità di farmaci biologici come analoghi della somatostatina, dopamino-agonisti, inibitori di mTOR, inibitori tirosino-chinasici. Più di recente interesse per l'andrologia, i tumori testicolari e le malattie genetiche della sfera andrologica

Keywords

neuroendocrine tumors (NETs)
Neuroendocrine neoplasms
multiple endocrine neoplasia type 1
Multiple Endocrine Neoplasia Type 2a/drug therapy
medullary thyroid cancer
Hyperparathyroidism
endocrine disrupting chemicals
Endocrine Gland Neoplasms
Endocrine function
andrological health
Pheochromocytoma

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma